<DOC>
	<DOCNO>NCT02530827</DOCNO>
	<brief_summary>Background : Several study report increased resting energy expenditure ( REE ) people live HIV/AIDS possibly due change body composition occur HIV lipodystrophy syndrome . The aim study evaluate influence use lipid-lowering drug rest energy expenditure ( REE ) total energy expenditure ( TEE ) patient seropositive HIV treatment lipodystrophy .</brief_summary>
	<brief_title>Energy Expenditure People Living With HIV/AIDS</brief_title>
	<detailed_description>REE measure indirect calorimetry . TEE measure doubly label water ( DLW ) technique activity monitor base accelerometry ( AM ) .</detailed_description>
	<mesh_term>Lipodystrophy</mesh_term>
	<mesh_term>HIV-Associated Lipodystrophy Syndrome</mesh_term>
	<mesh_term>Hypolipidemic Agents</mesh_term>
	<criteria>Use antiretroviral therapy least 4 month A cluster differentiation 4 ( CD4 ) Tcell count &gt; 200 cells/mm3 Use lipidlowering drug least 1 month ( group HIVseropositive lipodystrophy use lipidlowering ) Signs symptom opportunistic infection Thyroid disease</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>energy expenditure</keyword>
	<keyword>doubly labeled water</keyword>
	<keyword>accelerometer</keyword>
	<keyword>HIV</keyword>
	<keyword>lipodystrophy syndrome .</keyword>
</DOC>